<DOC>
	<DOCNO>NCT03026088</DOCNO>
	<brief_summary>This single-arm , open label , interventional , multi-center , phase IV pilot study .</brief_summary>
	<brief_title>Efficacy Oral Bisoprolol Heart Rate Reduction Chinese Chronic Heart Failure Subjects</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Bisoprolol</mesh_term>
	<criteria>1880 year , male female . Chronic Heart failure subject medical history cardiac disease relate cardiovascular disease . Left ventricular ejection fraction ( LVEF ) less equal ( = &lt; ) 40 percent ( % ) . New York Heart Association ( NYHA ) class II IV NYHA II ： Slight limitation physical activity . Comfortable rest , ordinary physical activity result undue breathlessness , fatigue palpitation . NYHA III：Marked limitation physical activity . Comfortable rest , less ordinary activity cause undue breathlessness , fatigue palpitation . NYHA IV：Unable carry physical activity without discomfort . Symptoms rest present . If physical activity undertaken , discomfort increase . Signed Informed Consent Form ( ICF ) . Acute coronary syndrome ( ACS ) within 3 month . Under betablocker treatment last 2 week . Under medicine treatment may affect heart rate , like Nondihydropyridine calcium channel blocker ( NDHPCCBs ) ivabradine last 2 week ; Under Digoxin treatment [ ( &gt; ) 0.125 milligram ( mg ) ] . Uncontrolled Diabetes [ hemoglobin A1c , ( HbA1c ) &gt; 7.5 % ] . Severe uncontrolled hypertension [ rest Systolic Blood Pressure ( SBP ) &gt; 180 millimeter mercury ( mmHg ) , rest Diastolic Blood Pressure ( DBP ) &gt; 110mmHg screening period ] . Severe hypotension [ rest SBP le ( &lt; ) 90mmHg , rest DBP &lt; 50mmHg ] . Resting heart rate &lt; 60 beat per minute ( bpm ) . Any contradiction Bisoprolol accord label , include : Acute heart failure episodes heart failure decompensation require intravenous inotropic therapy . Cardiogenic shock . Atrioventricular block second third degree ( without pacemaker ) . Sick sinus syndrome . Sinoatrial block . Slowed heart rate , cause symptom ( symptomatic bradycardia ) , Decreased blood pressure , cause symptom ( symptomatic hypotension ) , Severe bronchial asthma severe chronic obstructive pulmonary disease . Sever forms peripheral arterial occlusive disease Raynaud 's syndrome . Untreated phaeochromocytoma . Metabolic acidosis . Hypersensitivity bisoprolol excipients . Severe Arrhythmia include atrial fibrillation , atrial flutter , ventricular fibrillation , ventricular flutter ventricular tachycardia . Significant valvular heart disease , congenital heart disease , pulmonary heart disease perinatal heart disease . Acute pulmonary edema . Severe hepatic dysfunction , define : Serum Alanine Aminotransferase ( ALT ) &gt; triple upper limit normal range ; and/or Serum Aspartate Aminotransferase ( AST ) &gt; triple upper limit normal value range and/or Severe renal dysfunction , define : Serum creatinine &gt; twice upper limit normal range Chronic Kidney Disease ( glomerular filtration rate &lt; 45 Milliliter per minute ) . Hyperthyroidism hypothyroidism . Severe infectious disease , example ( eg ) Human Immunodeficiency Virus positive active tuberculosis . Severe autoimmune disease , e.g . lupus erythematosus , multiple sclerosis . Severe respiratory , digestive , hematological disease ( include Anemia Hb &lt; 100 gram per litre ) tumor . Known hypersensitivity Bisoprolol , excipient . Substance alcohol abuse . Received heart transplantation pacemaker implantation ; revascularization treatment within 3 month ; plan receive treatment 6 month . Currently undertake treatment may affect safety and/or efficacy evaluation , e.g . beta receptor agonist , et cetera . No legal ability legal ability limit . Subjects unlikely cooperate study inability unwillingness give inform consent . Childbearing period woman without effective contraceptive measure , pregnancy lactation . Participation another clinical trial within past 90 day . Other significant condition Investigator 's opinion would exclude subject trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Chronic Heart Failure</keyword>
	<keyword>Bisoprolol</keyword>
	<keyword>Heart rate control</keyword>
</DOC>